Detection of gastric carcinoma-associated MG7-Ag by serum immuno-PCR assay in a high-risk Chinese population, with implication for screening
✍ Scribed by Lian Zhang; Jun Ren; Kaifeng Pan; Junling Ma; Jiyou Li; Lin Shen; Xiaodong Zhang; Jie Li; Daiming Fan; Mitchell Gail; Weicheng You
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- French
- Weight
- 165 KB
- Volume
- 126
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
To evaluate gastric carcinoma‐associated antigen, MG7‐Ag, for detection of gastric cancer in a high‐risk population, a population‐based screening of gastric cancer was conducted in Linqu County, Shandong Province, China. In 2002 and 2003, a total of 2,710 participants aged 35–65 years received an endoscopic examination with 5 biopsies taken from standard sites with pathological diagnosis, and serum samples were collected to detect MG7‐Ag by serum‐based Immunopolymerase chain reaction (PCR) assay. The sensitivity and specificity of MG7‐Ag Immuno‐PCR assay in detecting of gastric cancer were assessed. Of 2,710 participants, 148 (5.46%) were determined to be MG7‐Ag positive. The sensitivity of MG7‐Ag Immuno‐PCR assay for the detection of gastric cancer was 77.5% (31 of 40 gastric cancer cases), the specificity was 95.62% (2,553 of 2,670 nongastric cancer subjects) and the accuracy was 73.12%. A total of 24 gastric cancer cases were in Stage I or II, of which 17 (70.8%) were MG7‐Ag positive. However, the proportion of MG7‐Ag positivity in subjects with superficial gastritis, chronic atrophic gastritis, intestinal metaplasia, indefinite dysplasia or dysplasia was ranged from 3.00% to 5.61% in comparison with 77.5% in those with gastric cancer. Our findings suggest that MG7‐Ag was a sensitive and specific serum biomarker and may have a potential for gastric cancer screening in the high‐risk population.